We describe three women who developed endometrial cancer after taking "bioidentical" hormone replacement therapy (HRT) to relieve menopausal symptoms. Although pharmaceutical HRT is a well established and tested therapy, little is known about the quality control, safety and efficacy of bioidentical HRT. Women should be advised to avoid bioidentical HRT, and those who continue to use it should receive regular endometrial surveillance.
No takes yet. Share an insight, caveat, or question.
Eden et al. (2007) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: